LEP and breast carcinoma: In functional studies, using equal quantities of vesicles, Lep-EVs were able in an autocrine manner to modulate the metabolism of recipient breast cancer cells, by increasing the production of ATP, a major driver of aggressive cancer cell phenotypes [55], and favoring the energy production by the mitochondrial phosphorylation.